metformin has been researched along with Cleft Spine in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this randomized, placebo-controlled study was to explore the effect of metformin in children with a neurogenic or myogenic motor deficit, who are therefore prone to develop overweight, adiposity, and insulin resistance." | 9.14 | Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. ( Casteels, K; Coudyzer, W; de Zegher, F; Fieuws, S; Goemans, N; Loeckx, D; van Helvoirt, M; Verpoorten, C, 2010) |
| "The aim of this randomized, placebo-controlled study was to explore the effect of metformin in children with a neurogenic or myogenic motor deficit, who are therefore prone to develop overweight, adiposity, and insulin resistance." | 5.14 | Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. ( Casteels, K; Coudyzer, W; de Zegher, F; Fieuws, S; Goemans, N; Loeckx, D; van Helvoirt, M; Verpoorten, C, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casteels, K | 1 |
| Fieuws, S | 1 |
| van Helvoirt, M | 1 |
| Verpoorten, C | 1 |
| Goemans, N | 1 |
| Coudyzer, W | 1 |
| Loeckx, D | 1 |
| de Zegher, F | 1 |
1 trial available for metformin and Cleft Spine
| Article | Year |
|---|---|
Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.
Topics: Adolescent; Blood Glucose; Body Mass Index; Child; Female; Humans; Hypoglycemic Agents; Insulin; Ins | 2010 |